Teacher Retirement System of Texas bought a new stake in Genpact Limited (NYSE:G - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 74,184 shares of the business services provider's stock, valued at approximately $3,186,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of G. SRH Advisors LLC acquired a new position in shares of Genpact in the fourth quarter valued at $26,000. Manchester Capital Management LLC bought a new stake in shares of Genpact during the 4th quarter worth about $38,000. Smartleaf Asset Management LLC increased its position in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock worth $41,000 after buying an additional 783 shares during the period. UMB Bank n.a. lifted its holdings in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after buying an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp boosted its position in shares of Genpact by 38.8% in the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock valued at $69,000 after acquiring an additional 453 shares during the period. Institutional investors own 96.03% of the company's stock.
Insider Buying and Selling
In other news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This trade represents a 7.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by corporate insiders.
Genpact Price Performance
Genpact stock traded down $0.75 during mid-day trading on Friday, reaching $50.00. The company had a trading volume of 1,088,529 shares, compared to its average volume of 1,355,537. The business has a fifty day simple moving average of $50.84 and a 200 day simple moving average of $45.07. The company has a market cap of $8.78 billion, a P/E ratio of 17.61, a P/E/G ratio of 1.84 and a beta of 1.16. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities research analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date was Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. Genpact's dividend payout ratio (DPR) is 23.94%.
Analysts Set New Price Targets
A number of equities analysts recently commented on the stock. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and raised their price target for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho raised their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Finally, Needham & Company LLC upped their target price on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Genpact has an average rating of "Hold" and a consensus price target of $48.44.
Read Our Latest Stock Analysis on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.